An official website of the United States government
Home
SEER Inquiry System - Report
Produced: 11/23/2024 9:58 AM
Question 20130187
Inquiry Details
References:
WHO Class Thymus Tumors
Question:
Reportability: Is a clinically diagnosed Stage III malignant thymoma reportable when the post-neoadjuvant resection showed spindle cell thymoma? See Discussion.
Discussion:
A thymoma is described by the medical oncologist at the time of the initial diagnosis as a malignant thymoma, Stage III. The patient had neoadjuvant CAP chemotherapy followed by a resection. Following the resection, the pathologist stated the diagnosis was spindle cell thymoma.
Answer:
A malignant thymoma is reportable. Based on the information provided, a reportable diagnosis (malignant thymoma) was made by a physician and the patient was treated for this diagnosis. Because there is no mention of the initial diagnosis being amended based on the resection specimen's pathology report, assume the initial diagnosis is still valid.
Cancer Site Category:
N/A
Data Item Category:
N/A
Other Category:
Reportability
Year:
2013
